Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University, Atlanta, Georgia.
Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University, Durham, North Carolina.
JAMA Netw Open. 2021 Nov 1;4(11):e2131674. doi: 10.1001/jamanetworkopen.2021.31674.
Discrepancies in oxygen saturation measured by pulse oximetry (Spo2), when compared with arterial oxygen saturation (Sao2) measured by arterial blood gas (ABG), may differentially affect patients according to race and ethnicity. However, the association of these disparities with health outcomes is unknown.
To examine racial and ethnic discrepancies between Sao2 and Spo2 measures and their associations with clinical outcomes.
DESIGN, SETTING, AND PARTICIPANTS: This multicenter, retrospective, cross-sectional study included 3 publicly available electronic health record (EHR) databases (ie, the Electronic Intensive Care Unit-Clinical Research Database and Medical Information Mart for Intensive Care III and IV) as well as Emory Healthcare (2014-2021) and Grady Memorial (2014-2020) databases, spanning 215 hospitals and 382 ICUs. From 141 600 hospital encounters with recorded ABG measurements, 87 971 participants with first ABG measurements and an Spo2 of at least 88% within 5 minutes before the ABG test were included.
Patients with hidden hypoxemia (ie, Spo2 ≥88% but Sao2 <88%).
Outcomes, stratified by race and ethnicity, were Sao2 for each Spo2, hidden hypoxemia prevalence, initial demographic characteristics (age, sex), clinical outcomes (in-hospital mortality, length of stay), organ dysfunction by scores (Sequential Organ Failure Assessment [SOFA]), and laboratory values (lactate and creatinine levels) before and 24 hours after the ABG measurement.
The first Spo2-Sao2 pairs from 87 971 patient encounters (27 713 [42.9%] women; mean [SE] age, 62.2 [17.0] years; 1919 [2.3%] Asian patients; 26 032 [29.6%] Black patients; 2397 [2.7%] Hispanic patients, and 57 632 [65.5%] White patients) were analyzed, with 4859 (5.5%) having hidden hypoxemia. Hidden hypoxemia was observed in all subgroups with varying incidence (Black: 1785 [6.8%]; Hispanic: 160 [6.0%]; Asian: 92 [4.8%]; White: 2822 [4.9%]) and was associated with greater organ dysfunction 24 hours after the ABG measurement, as evidenced by higher mean (SE) SOFA scores (7.2 [0.1] vs 6.29 [0.02]) and higher in-hospital mortality (eg, among Black patients: 369 [21.1%] vs 3557 [15.0%]; P < .001). Furthermore, patients with hidden hypoxemia had higher mean (SE) lactate levels before (3.15 [0.09] mg/dL vs 2.66 [0.02] mg/dL) and 24 hours after (2.83 [0.14] mg/dL vs 2.27 [0.02] mg/dL) the ABG test, with less lactate clearance (-0.54 [0.12] mg/dL vs -0.79 [0.03] mg/dL).
In this study, there was greater variability in oxygen saturation levels for a given Spo2 level in patients who self-identified as Black, followed by Hispanic, Asian, and White. Patients with and without hidden hypoxemia were demographically and clinically similar at baseline ABG measurement by SOFA scores, but those with hidden hypoxemia subsequently experienced higher organ dysfunction scores and higher in-hospital mortality.
与通过动脉血气 (ABG) 测量的动脉血氧饱和度 (Sao2) 相比,脉搏血氧饱和度 (Spo2) 的测量值存在差异,这可能会根据种族和民族的不同而对患者产生不同的影响。然而,这些差异与健康结果的关联尚不清楚。
检查 Sao2 和 Spo2 测量值之间的种族和民族差异及其与临床结果的关联。
设计、设置和参与者:这项多中心、回顾性、横断面研究纳入了 3 个公开的电子健康记录 (EHR) 数据库(即电子重症监护病房临床研究数据库和医疗信息集市重症监护 III 和 IV)以及埃默里医疗保健公司 (2014-2021 年) 和格雷迪纪念医院 (2014-2020 年),涵盖了 215 家医院和 382 个 ICU。从 141600 例有 ABG 测量记录的住院患者中,纳入了 87971 例首次 ABG 测量值且 Spo2 在 ABG 测试前至少 5 分钟内至少为 88%的患者。
存在隐匿性低氧血症的患者(即,Spo2≥88%但 Sao2<88%)。
根据种族和民族分层的结局包括每个 Spo2 的 Sao2、隐匿性低氧血症的患病率、初始人口统计学特征(年龄、性别)、临床结局(院内死亡率、住院时间)、器官功能障碍评分(序贯器官衰竭评估 [SOFA])以及 ABG 测量前后 24 小时的实验室值(乳酸和肌酐水平)。
对 87971 例患者就诊的首次 Spo2-Sao2 对(27713[42.9%]名女性;平均[SE]年龄为 62.2[17.0]岁;1919[2.3%]名亚裔患者;26032[29.6%]名黑人患者;2397[2.7%]名西班牙裔患者和 57632[65.5%]名白人患者)进行了分析,其中 4859 例(5.5%)存在隐匿性低氧血症。在所有亚组中均观察到隐匿性低氧血症,其发生率不同(黑人:1785[6.8%];西班牙裔:160[6.0%];亚裔:92[4.8%];白人:2822[4.9%]),并且与 ABG 测量后 24 小时更高的器官功能障碍相关,表现为更高的平均(SE)SOFA 评分(7.2[0.1]vs 6.29[0.02])和更高的院内死亡率(例如,黑人患者:369[21.1%]vs 3557[15.0%];P<.001)。此外,隐匿性低氧血症患者在 ABG 测试前后的平均(SE)乳酸水平更高(前:3.15[0.09]mg/dL vs 2.66[0.02]mg/dL;后:2.83[0.14]mg/dL vs 2.27[0.02]mg/dL),并且乳酸清除率更低(前:-0.54[0.12]mg/dL vs -0.79[0.03]mg/dL)。
在这项研究中,自我认同为黑人的患者的 Spo2 水平与 Sao2 水平的差异更大,其次是西班牙裔、亚裔和白人。隐匿性低氧血症患者和无隐匿性低氧血症患者在 ABG 测量时的 SOFA 评分等人口统计学和临床特征相似,但隐匿性低氧血症患者随后出现更高的器官功能障碍评分和更高的院内死亡率。